Allergic bronchopulmonary aspergillosis

Annual Review of Medicine

Volumn 50, Issue , 1999, Pages 303-316

  Cockrill, B A ^a   Hales, C A ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Aspergillosis; Asthma; Bronchiectasis; Cystic fibrosis

Indexed keywords

IMMUNOGLOBULIN E; ITRACONAZOLE; PREDNISONE;

ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHIECTASIS; BRONCHOPULMONARY ASPERGILLOMA; CORTICOSTEROID THERAPY; CYSTIC FIBROSIS; HUMAN; IMMUNE RESPONSE; IMMUNOGLOBULIN BLOOD LEVEL; LUNG FIBROSIS; LUNG INFILTRATE; MUCUS SECRETION; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; REVIEW; WHEEZING;

ADMINISTRATION, ORAL; ASPERGILLOSIS, ALLERGIC BRONCHOPULMONARY; ASPERGILLUS FUMIGATUS; ASTHMA; BRONCHIECTASIS; CYSTIC FIBROSIS; DISEASE PROGRESSION; GLUCOCORTICOIDS; HUMANS; IMMUNOGLOBULIN E; LUNG; MUCUS; PULMONARY FIBROSIS; RECURRENCE; RESPIRATORY SOUNDS;

EID: 0033017536     PISSN: 00664219     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.med.50.1.303     Document Type: Review

References (38)

1. 1. Hinson KFW, Moon AJ, Plummer NS. 1952. Bronchopulmonary aspergillosis. Thorax 7:317-33
2. 1a. Greenberger PA, Patterson R. 1986. Diagnosis and management of allergic bronchopulmonary aspergillosis. Ann. Allergy 56:444-52
3. 1b. Kauffman HF, Zuidema S, de Monchy JGR. 1994. Clinical significance of fungal allergy: aerobiological and clinical studies. In Health Implications of Fungi in Indoor Environments, ed. RA Samson, B Flannigan, ME Flannigan, et al, pp. 221-28. Amsterdam: Elsevier
4. 2. Kauffman HF, Tomee JFC, Van der Werf TS, et al. 1995. Review of fungus-induced asthmatic reactions. Am. J. Respir. Crit. Care Med. 151:2109-116
5. 3. Radin RC, Greenberger PA, Patterson R, Ghory A. 1983. Mould counts and exacerbations of allergic bronchopulmonary aspergillosis. Clin. Allergy 13(3):271-75
6. 4. Schuyler M. 1998. The Th1/Th2 paradigm in allergic bronchopulmonary aspergillosis. J. Lab. Clin. Med. 131(3): 194-96
7. 5. Slavin RG, Físcher VW, Levine EA, et al. 1978. A primate model of allergic bronchopulmonary aspergillosis. Int. Arch. Allergy Appl. Immunol. 56(4):325-33
8. 6. Wang JL, Patterson R, Rosenberg M, et al. 1978. Serum IgE and IgG antibody activity against Aspergillus fumigatus as a diagnostic aid in allergic aspergillosis. Am. Rev. Respir. Dis. 117:917-27
9. 6a. Murali PS, Kurup VP, Bansal NK, et al. 1998. IgE down regulation and cytokine induction by Aspergillus antigens in human allergic bronchopulmonary aspergillosis. J. Lab. Clin. Med. 131:228-35
10. 7. Knutsen AP, Mueller KR, Hutcheson PS, Slavin RG. 1994. Serum anti-Aspergillus fumigatus antibodies by immunoblot and ELISA in cystic fibrosis with allergic bronchopulmonary aspergillosis. J. Allergy Clin. Immunol. 93(5):926-31
11. 8. Maiz L, Cuevas M, Quirce S, et al. 1997. Allergic bronchopulmonary aspergillosis with low serum IgE levels in a child with cystic fibrosis. J. Allergy Clin. Immunol. 100:431-32
12. 9. Schwartz HJ, Berger M, Hostoffer R. 1996. Allergic bronchopulmonary aspergillosis and common variable hypogammaglobulinemia in an adult male patient: case report. J. Allergy Clin. Immunol. 98: 708-10
13. 10. Madan T, Kishore U, Shah A, et al. 1997. Lung surfactant proteins A and D can inhibit specific IgE binding to the allergens of Aspergillus fumigatus and block allergen-induced histamine release from human basophils. Clin. Exp. Immunol. 110:241-49
14. 11. Chauhan B, Knutsen AP, Hutcheson PS, et al. 1996. T cell subsets epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis. J. Clin. Invest. 97:2324-31
15. 12. Chauhan B, Santiago L, Kirschmann DA, et al. 1997. The association of HLA-DR alleles and T cell activation with allergic bronchopulmonary aspergillosis. J. Clin. Invest. 159:4072-76
16. 14. Krouwels FH, van der Heijden JF, Lutter R, et al. 1996. Glucocorticosteroids affect functions of airway-and blood-derived human T-cell clones, favoring the Th1 profile through two mechanisms. Am. J. Respir. Cell Mol. Biol. 14(4):388-97
17. 15. Bonfield TL, Konstan MW, Burfeind P, et al. 1995. Normal bronchial epithelial cells constitutively produce the anti-inflammatory cytokine interleukin-10, which is downregulated in cystic fibrosis Am. J. Respir. Cell Mol. Biol. 3(3):257-61
18. 16. Nicod L, Habre F, Dayer JM, Boehringer N. 1995. Interleukin-10 decreases tumor necrosis factor alpha and beta in alloreactions induced by human lung dendritic cells and macrophages. Am. J. Respir. Cell Mol. Biol. 13(1):83-90
19. 17. Mehrian R, Quismorio FP Jr, Strassman G, et al. 1998. Synergistic effect between IL-10 and bcl-2 genotypes in determining susceptibility to systemic lupus erythematosus. Arthritis Rheum. 41(4):596-602
20. 18. Grunig G, Corry DB, Leach MW, et al. 1997. lnterleukin-10 is a natural suppressor of cytokine production and inflammation in a murine model of allergic bronchopulmonary aspergillosis. J. Exp. Med. 185(6):1089-99
21. 19. Miller PW, Hamosh A, Macek J, et al. 1996. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in allergic bronchopulmonary aspergillosis. J. Exp. Med. 59(1):45-51
22. 20. Fitzsimmons EJ, Aris R, Patterson R. 1997. Recurrence of allergic bronchopulmonary aspergillosis in the post-transplant lungs of a cystic fibrosis patient. Chest 112:281-82
23. 21. Bosken CH, Myers JL, Greenberger PA, Katzenstein A-L. 1988. Pathologic features of allergic bronchopulmonary aspergillosis. Am. J. Surg. Pathol. 12(3):216-22
24. 22. Case records of the Massachusetts General Hospital. 1993. Weekly clinicopathological exercises. Case 45-1993. A 23-year-old asthmatic man with pulmonary infiltrates and hilar lymphadenopathy. N. Engl. J. Med 329(20):1484-91
25. 23. Patterson R, Greenberger PA, Radin RC, Roberts M. 1982. Allergic bronchopulmonary aspergillosis: staging as an aid to management. Ann. Int. Med. 96:286-91
26. 24. Wardlaw A, Geddes DM. 1992. Allergic bronchopulmonary aspergillosis: a review. J. R. Soc. Med. 85(12):747-51
27. 25. Wang JL, Patterson R, Roberts M, Ghory AC. 1979. The management of allergic bronchopulmonary aspergillosis. Am. Rev. Respir. Dis. 120(1):87-92
28. 26. Patterson R, Greenberger PA, Ricketti AJ, Roberts M. 1983. A radioimmunoassay index for allergic bronchopulmonary aspergillosis. Ann. Int. Med. 99:18-22
29. 27. Patterson R, Greenberger PA, Halwig M, et al. 1985. Allergic bronchopulmonary aspergillosis. Natural history and classification of early disease by serologic and roentgenographic studies. Arch. Intern. Med. 146:916-18
30. 28. Benatar SR, Allan B, Hewitson RP, Don PA. 1980. Allergic bronchopulmonary stemphyliosis. Thorax 35(7):515-18
31. 29. Travis WD, Kwon-Chung KJ, Kleiner DE, et al. 1991. Unusual aspects of allergic bronchopulmonary fungal disease: report of two cases due to Curvularia organisms associated with allergic fungal sinusitis. Hum. Pathol. 22(12):1240-48
32. 30. Lee PH, Carr DH, Rubens MB, et al. 1995. Accuracy of CT in predicting the cause of bronchiectasis. Clin. Radiol. 50(12):839-41
33. 31. Lynch DA. 1998. Imaging of asthma and allergic bronchopulmonary mycosis. Radiol. Clin. No. Am. 36(1):129-42
34. 32. Neeld DA, Goodman LR, Gurney JW, et al. 1990. Computerized tomography in the evaluation of allergic bronchopulmonary aspergillosis. Am. Rev. Respir. Dis. 142:1200-5
35. 33. Reiff DB, Wells AU, Carr DH, et al. 1995. CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. Am. J. Roentgenol. 165(2):261-67
36. 34. Panchal N, Pant C, Bhagat R, Shah A. 1994. Central bronchiectasis in allergic bronchopulmonary aspergillosis: comparative evaluation of computed tomography of the thorax with bronchography. Eur. Respir. J. 7:1290-93
37. 35. Denning DW, Van Wye JE, Lewiston NJ, Stevens DA. 1991. Adjunctive therapy of allergic bronchopulmonary aspergillosis with itraconazole. Chest 100:813-19
38. 36. Germaud P, Tuchais E. 1995. Allergic bronchopulmonary aspergillosis treated with itraconazole (letter). Chest 107(3): 883